Skip to main content
. 2019 Mar;5(1):53–60. doi: 10.18383/j.tom.2018.00031

Figure 6.

Figure 6.

Longitudinal imaging of a patient in the belinostat (treatment) arm of the study. An sMRI map of choline indicates a response to chemoradiation as assessed at 1 month post-RT. Additional follow-up imaging indicates the pseudoprogression phenomenon occurring at 3 month post-RT, resolving by 4 month post-RT.